Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Illumina; Rosetta Genomics; Chronix Biomedical; Caris Life Sciences; Babraham Institute

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Illumina announced this week that it has cut the price on its individual genome sequencing service to $19,500. The firm also said that the price would be $14,500 per genome for groups of five participants using the same physician. Last June, Illumina partnered with four consumer genomics firms to bring whole-genome sequencing analysis of genetic risk information to customers. The initial cost of the service was $48,000.


Rosetta Genomics this week formed a majority-owned subsidiary called Rosetta Green, which is focused on microRNA-based agricultural and clean technology applications. Rosetta said that it holds a 76 percent stake in the new subsidiary. Rosetta Green also has received $1.5 million in funding from outside investors and has received funding from the Israeli Office of the Chief Scientist.


Chronix Biomedical said that it has launched a new disease detection and monitoring service for cancer researchers using its Apoptotic DNA Blood Test, which analyzes apoptotic DNA from dead and dying cells to identify and track ongoing changes associated with specific cancers and other chronic diseases.


Caris Life Sciences said this week that it has moved into a new corporate headquarters in the Dallas area that is three times larger than its previous facility. It also said that it has tripled its space in Phoenix with a new facility that conducts R&D on molecular tests for cancer.


Researchers at the Babraham Institute have been awarded a £900,000 ($1.3 million) grant to conduct studies in epigenetic regulation in partnership with biotech firm CellCentric. The funding is being provided by the UK's Biotechnology and Biological Sciences Research Council.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.